TY - JOUR AU - Keller, M. B. AU - McCullough, J. P. AU - Klein, D. N. PY - 2000 DA - 2000// TI - A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200005183422001 DO - 10.1056/NEJM200005183422001 ID - Keller2000 ER - TY - STD TI - Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40. ID - ref2 ER - TY - STD TI - Anthony DC, Couch Y, Losey P et al. The systemic response to brain injury and disease. Brain Behav Immun. 2012;26(4):534–40. ID - ref3 ER - TY - JOUR AU - Capuron, L. AU - Miller, A. H. PY - 2011 DA - 2011// TI - Immune system to brain signaling: neuropsychopharmacological implications JO - Pharmacol Ther VL - 130 UR - https://doi.org/10.1016/j.pharmthera.2011.01.014 DO - 10.1016/j.pharmthera.2011.01.014 ID - Capuron2011 ER - TY - STD TI - Louveau A, Smirnov I, Keyes TJ et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337–41. ID - ref5 ER - TY - JOUR AU - Dantzer, R. PY - 2009 DA - 2009// TI - Cytokine, sickness behavior, and depression JO - Immunol Allergy Clin N Am VL - 29 UR - https://doi.org/10.1016/j.iac.2009.02.002 DO - 10.1016/j.iac.2009.02.002 ID - Dantzer2009 ER - TY - JOUR AU - Dantzer, R. AU - Kelley, K. W. PY - 2007 DA - 2007// TI - Twenty years of research on cytokine-induced sickness behavior JO - Brain Behav Immun VL - 21 UR - https://doi.org/10.1016/j.bbi.2006.09.006 DO - 10.1016/j.bbi.2006.09.006 ID - Dantzer2007 ER - TY - STD TI - Kelley KW, Bluthe RM, Dantzer R et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17(Suppl 1):S112–8. ID - ref8 ER - TY - JOUR AU - Raison, C. L. AU - Capuron, L. AU - Miller, A. H. PY - 2006 DA - 2006// TI - Cytokines sing the blues: inflammation and the pathogenesis of depression JO - Trends Immunol VL - 27 UR - https://doi.org/10.1016/j.it.2005.11.006 DO - 10.1016/j.it.2005.11.006 ID - Raison2006 ER - TY - STD TI - Eggermont AMM, Suciu S, Santinami M et al. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet. 2008;372(9633):117–26. ID - ref10 ER - TY - STD TI - Friebe A, Horn M, Schmidt F et al. Dose-dependent development of depressive symptoms during adjuvant interferon-alpha treatment of patients with malignant melanoma. Psychosomatics. 2010;51(6):466–73. ID - ref11 ER - TY - JOUR AU - Reichenberg, A. AU - Gorman, J. M. AU - Dieterich DT. PY - 2005 DA - 2005// TI - Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000192087.64432.ae DO - 10.1097/01.aids.0000192087.64432.ae ID - Reichenberg2005 ER - TY - JOUR AU - Capuron, L. AU - Miller, A. H. PY - 2004 DA - 2004// TI - Cytokines and psychopathology: lessons from interferon-alpha JO - Biol Psychiatry VL - 56 UR - https://doi.org/10.1016/j.biopsych.2004.02.009 DO - 10.1016/j.biopsych.2004.02.009 ID - Capuron2004 ER - TY - STD TI - Raison CL, Demetrashvili M, Capuron L et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs. 2005;19(2):105–23. ID - ref14 ER - TY - STD TI - Baraldi S, Hepgul N, Mondelli V et al. Symptomatic treatment of interferon-alpha-induced depression in hepatitis C: a systematic review. J Clin Psychopharmacol. 2012;32(4):531–43. ID - ref15 ER - TY - STD TI - Hou XJ, Xu JH, Wang J et al. Can antidepressants prevent pegylated interferon-alpha/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials? PLoS One. 2013;8(10):e76799. ID - ref16 ER - TY - STD TI - Benros ME, Waltoft BL, Nordentoft M et al. Autoimmune diseases and severe infections as risk factors for mood disorders a Nationwide study. JAMA Psychiatry. 2013;70(8):812–20. ID - ref17 ER - TY - STD TI - Dickens C, McGowan L, Clark-Carter D et al. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med. 2002;64(1):52–60. ID - ref18 ER - TY - STD TI - Korczak DJ, Pereira S, Koulajian K et al. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia. 2011;54(10):2483–93. ID - ref19 ER - TY - STD TI - Wium-Andersen MK, Orsted DD, Nielsen SF et al. Elevated C-reactive protein levels, psychological distress, and depression in 73131 individuals. JAMA Psychiatry. 2013;70(2):176–84. ID - ref20 ER - TY - JOUR AU - Castanon, N. AU - Lasselin, J. AU - Capuron L PY - 2014 DA - 2014// TI - Neuropsychiatric comorbidity in obesity: role of inflammatory processes JO - Front Endocrinol (Lausanne) VL - 5 ID - Castanon2014 ER - TY - JOUR AU - Castanon, N. AU - Luheshi, G. AU - Laye, S. PY - 2015 DA - 2015// TI - Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity JO - Front Neurosci VL - 9 UR - https://doi.org/10.3389/fnins.2015.00229 DO - 10.3389/fnins.2015.00229 ID - Castanon2015 ER - TY - STD TI - Dowlati Y, Herrman N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–57. ID - ref23 ER - TY - JOUR AU - Goldsmith, D. R. AU - Rapaport, M. H. AU - Miller, B. J. PY - 2016 DA - 2016// TI - A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression JO - Mol Psychiatry VL - 21 UR - https://doi.org/10.1038/mp.2016.3 DO - 10.1038/mp.2016.3 ID - Goldsmith2016 ER - TY - JOUR AU - Howren, M. B. AU - Lamkin, D. M. AU - Suls, J. PY - 2009 DA - 2009// TI - Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis JO - Psychosom Med VL - 71 UR - https://doi.org/10.1097/PSY.0b013e3181907c1b DO - 10.1097/PSY.0b013e3181907c1b ID - Howren2009 ER - TY - STD TI - Dahl J, Ormstad H, Aass HCD et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 2014;45:77–86. ID - ref26 ER - TY - JOUR AU - Liu, Y. AU - Ho, R. C. M. AU - Mak, A. PY - 2012 DA - 2012// TI - Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression JO - J Affect Disord VL - 139 UR - https://doi.org/10.1016/j.jad.2011.08.003 DO - 10.1016/j.jad.2011.08.003 ID - Liu2012 ER - TY - STD TI - Setiawan E, Wilson AA, Mizrahi R et al. Role of Translocator protein density, a marker of Neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72(3):268–75. ID - ref28 ER - TY - JOUR AU - Valkanova, V. AU - Ebmeier, K. P. AU - Allan, C. L. PY - 2013 DA - 2013// TI - CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies JO - J Affect Disord VL - 150 UR - https://doi.org/10.1016/j.jad.2013.06.004 DO - 10.1016/j.jad.2013.06.004 ID - Valkanova2013 ER - TY - STD TI - Kohler-Forsberg O, Buttenschon HN, Tansey KE et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344–50. ID - ref30 ER - TY - STD TI - Hope S, Ueland T, Steen NE et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res. 2013;145(1–3):36–42. ID - ref31 ER - TY - STD TI - Kohler O, Petersen L, Mors O et al. Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study. Acta Psychiatr Scand. 2017;135(2):97–105. ID - ref32 ER - TY - STD TI - Krogh J, Benros ME, Jorgensen MB et al. The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav Immun. 2014;35:70–6. ID - ref33 ER - TY - STD TI - Raison CL, Rutherford RE, Woolwine BJ et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression. JAMA Psychiatry. 2013;70(1):31–41. ID - ref34 ER - TY - STD TI - Kappelmann N, Lewis G, Dantzer R et al. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2018;23(2):335–43. ID - ref35 ER - TY - JOUR AU - Eyre, H. A. AU - Baune, B. T. PY - 2015 DA - 2015// TI - Anti-inflammatory intervention in depression JO - JAMA Psychiatry VL - 72 UR - https://doi.org/10.1001/jamapsychiatry.2014.3128 DO - 10.1001/jamapsychiatry.2014.3128 ID - Eyre2015 ER - TY - JOUR AU - Eyre, H. A. AU - Stuart, M. J. AU - Baune, B. T. PY - 2014 DA - 2014// TI - A phase-specific neuroimmune model of clinical depression JO - Prog Neuro-Psychopharmacol Biol Psychiatry VL - 54 UR - https://doi.org/10.1016/j.pnpbp.2014.06.011 DO - 10.1016/j.pnpbp.2014.06.011 ID - Eyre2014 ER - TY - STD TI - Eyre HA, Air T, Proctor S et al. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2015;57:11–6. ID - ref38 ER - TY - STD TI - Malhi GS, Bassett D, Boyce D et al. Royal Australian and new Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49(12):1087–206. ID - ref39 ER - TY - STD TI - McIntyre RS, Harrison J, Loft H et al. The effects of Vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol. 2016 Oct; 19(10): pyw055. ID - ref40 ER - TY - STD TI - Kohler O, Benros ME, Nordentoft M et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014;71(12):1381–91. ID - ref41 ER - TY - STD TI - Na KS, Lee KJ, Lee JS et al. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:79–85. ID - ref42 ER - TY - STD TI - Chen G, Lee R, Hojer AM et al. Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant. Clin Drug Investig. 2013;33(10):727–36. ID - ref43 ER - TY - STD TI - Areberg J, Petersen KB, Chen G et al. Population pharmacokinetic meta-analysis of vortioxetine in healthy individuals. Basic Clin Pharmacol Toxicol. 2014;115(6):552–9. ID - ref44 ER - TY - STD TI - Abbasi SH, Hosseini F, Modabbernia A et al. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012;141(2–3):308–14. ID - ref45 ER - TY - STD TI - Akhondzadeh S, Jafari S, Raisi F et al. Clinical trial of adjunctive CELECOXIB treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607–11. ID - ref46 ER - TY - STD TI - Muller N, Schwarz MJ, Dehning S et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006;11(7):680–4. ID - ref47 ER - TY - STD TI - Majd M, Hashemian F, Hosseini SM et al. A randomized, double-blind, placebo-controlled trial of Celecoxib augmentation of sertraline in treatment of drug-naive depressed women: a pilot study. Iran J Pharm Res. 2015;14(3):891–9. ID - ref48 ER - TY - JOUR AU - Montgomery, S. A. AU - Asberg, M. PY - 1979 DA - 1979// TI - A new depression scale designed to be sensitive to change JO - Br J Psychiatry VL - 134 UR - https://doi.org/10.1192/bjp.134.4.382 DO - 10.1192/bjp.134.4.382 ID - Montgomery1979 ER - TY - JOUR AU - Baune, B. T. AU - Air, T. PY - 2016 DA - 2016// TI - Clinical, functional, and biological correlates of cognitive dimensions in major depressive disorder - rationale, design, and characteristics of the cognitive function and mood study (CoFaM-study) JO - Front Psychiatry VL - 7 UR - https://doi.org/10.3389/fpsyt.2016.00150 DO - 10.3389/fpsyt.2016.00150 ID - Baune2016 ER - TY - STD TI - Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 34–57 ID - ref51 ER - TY - STD TI - Interian A, Chesin M, Kline A et al. Use of the Columbia-Suicide Severity Rating Scale (C-SSRS) to classify suicidal behaviors. Arch Suicide Res. 2018;22(2):278–94. ID - ref52 ER - TY - JOUR AU - Mockler, D. AU - Riordan, J. AU - Sharma, T. PY - 1996 DA - 1996// TI - A comparison of the NART (restandardized) and the NART-R (revised) JO - Br J Clin Psychol VL - 35 UR - https://doi.org/10.1111/j.2044-8260.1996.tb01212.x DO - 10.1111/j.2044-8260.1996.tb01212.x ID - Mockler1996 ER - TY - JOUR AU - Busner, J. AU - Targum, S. D. PY - 2007 DA - 2007// TI - The clinical global impressions scale: applying a research tool in clinical practice JO - Psychiatry (Edgmont) VL - 4 ID - Busner2007 ER - TY - STD TI - Rosa AR, Sanchez-Moreno J, Martinez-Aran A et al. Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5. ID - ref55 ER - TY - STD TI - Krieger T, Zimmermann J, Huffziger S et al. Measuring depression with a well-being index: further evidence for the validity of the WHO well-being index (WHO-5) as a measure of the severity of depression. J Affect Disord. 2014;156:240–4. ID - ref56 ER - TY - STD TI - Despiegel N, Danchenko N, Francois C et al. The use and performance of productivity scales to evaluate presenteeism in mood disorders. Value Health. 2012;15(8):1148–61. ID - ref57 ER - TY - STD TI - McIntyre RS, Harrison J, Loft H et al. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry. 2017;78(7):873–81. ID - ref58 ER - TY - STD TI - Lanas A, Goldstein JL, Chan FK et al. Risk factors associated with a decrease >/=2 g/dL in haemoglobin and/or >/=10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). Aliment Pharmacol Ther. 2012;36(5):485–92. ID - ref59 ER - TY - STD TI - Tomizawa M, Shinozaki F, Hasegawa R et al. Low hemoglobin levels are associated with upper gastrointestinal bleeding. Biomed Rep. 2016;5(3):349–52. ID - ref60 ER - TY - STD TI - Hooper R, Forbes A, Hemming K et al. Analysis of cluster randomised trials with an assessment of outcome at baseline. BMJ. 2018;360:k1121. ID - ref61 ER - TY - STD TI - Eyre HA, Air T, Pradhan A et al. A meta-analysis of chemokines in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;68:1–8. ID - ref62 ER - TY - STD TI - Udina M, Moreno-Espana J, Capuron L et al. Cytokine-induced depression: current status and novel targets for depression therapy. CNS Neurol Disord Drug Targets. 2014;13(6):1066–74. ID - ref63 ER - TY - STD TI - Dantzer R, O'Connor JC, Freund GG et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. ID - ref64 ER - TY - STD TI - Dantzer R, O'Connor JC, Lawson MA et al. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36(3):426–36. ID - ref65 ER -